Gilman Hill Asset Management, LLC Abbott Laboratories Transaction History

Gilman Hill Asset Management, LLC

$594 Million
Q3 2024

A detailed history of Gilman Hill Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gilman Hill Asset Management, LLC holds 9,548 shares of ABT stock, worth $1.13 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

9,548

Previous 9,423 1.33%

Holding current value

$1.13 Million

Previous $979,000 11.13%

% of portfolio

0.18%

Previous 0.18%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$100.07 - $118.13 $12,508 - $14,766	125 Added 1.33%	9,548 $1.09 Million
Q1 2024 Apr 12, 2024	BUY	$109.52 - $120.96 $109 - $120	1 Added 0.01%	9,423 $1.07 Million
Q3 2023 Oct 13, 2023	SELL	$95.53 - $114.62 $95 - $114	-1 Reduced 0.01%	9,422 $912,000
Q2 2023 Jul 14, 2023	SELL	$100.78 - $112.29 $37,792 - $42,108	-375 Reduced 3.83%	9,423 $1.03 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $72,645 - $85,507	-750 Reduced 7.11%	9,798 $992,000
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $83,082 - $97,468	-874 Reduced 7.65%	10,548 $0
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $168,459 - $195,044	-1,741 Reduced 13.23%	11,422 $1.11 Million
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $86,249 - $104,247	-845 Reduced 6.03%	13,163 $1.43 Million
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $10,261 - $12,513	90 Added 0.65%	14,008 $1.66 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $9,242 - $11,316	-80 Reduced 0.57%	13,918 $1.96 Million
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $152,376 - $179,522	1,400 Added 11.11%	13,998 $1.68 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $62,475 - $68,079	595 Added 4.96%	12,598 $1.38 Million
Q1 2020 Apr 22, 2020	SELL	$62.82 - $91.86 $48,999 - $71,650	-780 Reduced 6.1%	12,003 $947,000
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $51,150 - $55,462	-625 Reduced 4.66%	12,783 $1.07 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $23,686 - $27,625	-325 Reduced 2.37%	13,408 $1.13 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $70,126 - $84,783	-1,059 Reduced 7.16%	13,733 $1.1 Million
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $476,949 - $540,314	7,275 Added 96.78%	14,792 $1.07 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $7,196 - $7,942	-125 Reduced 1.64%	7,517 $458,000
Q1 2018 Apr 26, 2018	SELL	$56.27 - $63.62 $434,629 - $491,400	-7,724 Reduced 50.27%	7,642 $458,000
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $1,288 - $1,379	-24 Reduced 0.16%	15,366 $877,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $739,643 - $825,519	15,390	15,390 $821,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.

Account

Gilman Hill Asset Management, LLC Abbott Laboratories Transaction History